Ntowe Koumani W, Thomas Samantha M, Dalton Juliet C, Olunuga Ebunoluwa, Wang Ton, Chiba Akiko, Plichta Jennifer K
Department of Surgery, Duke University Medical Center, 2301 Erwin Rd, Durham, NC, 27707, USA.
Duke Cancer Institute, Duke University, 10 Bryan Searle Drive, Durham, NC, 27710, USA; Department of Biostatistics and Bioinformatics, Duke University, 40 Duke Medicine Circle, Durham, NC, 27710, USA.
Am J Surg. 2025 Sep;247:116485. doi: 10.1016/j.amjsurg.2025.116485. Epub 2025 Jun 18.
We compared rates of risk reducing mastectomies (RRM) in patients with breast cancer (BC)-related pathogenic variants.
Female patients ages ≥18 with a BC-related pathogenic variant, without a concurrent or prior BC diagnosis, were identified from a single academic center's database. Patients were stratified by BRCA mutations, high penetrance mutations (HPM), and moderate penetrance mutations (MPM). Race and ethnicity were classified as non-Hispanic White (NHW), non-Hispanic Black (NHB), non-Hispanic other (NHO), and Hispanic.
Our study included 528 patients, which included 79.2 % (n = 418) NHW, 7.0 % (n = 37) NHB, 3.6 % (n = 19) NHO, and 3.4 % (n = 18) Hispanic patients. Overall, 16.5 % of patients underwent RRM: 18.4 % of NHW, 10.8 % of NHB, 5.6 % of Hispanic (p = 0.45). For NHB and Hispanic patients, no individuals with HPMs (NHB 0/6, Hispanic 0/5) or MPMs (NHB 0/11, Hispanic 0/4) underwent RRM.
Our findings suggest that race and ethnicity may be associated with the decision to undergo RRM.
我们比较了患有乳腺癌(BC)相关致病变异患者的降低风险乳房切除术(RRM)发生率。
从一个学术中心的数据库中识别出年龄≥18岁、患有BC相关致病变异且无同时期或既往BC诊断的女性患者。患者按BRCA突变、高 penetrance 突变(HPM)和中等 penetrance 突变(MPM)进行分层。种族和族裔分为非西班牙裔白人(NHW)、非西班牙裔黑人(NHB)、非西班牙裔其他(NHO)和西班牙裔。
我们的研究纳入了528名患者,其中包括79.2%(n = 418)的NHW、7.0%(n = 37)的NHB、3.6%(n = 19)的NHO和3.4%(n = 18)的西班牙裔患者。总体而言,16.5%的患者接受了RRM:NHW为18.4%,NHB为10.8%,西班牙裔为5.6%(p = 0.45)。对于NHB和西班牙裔患者,没有携带HPMs(NHB为0/6,西班牙裔为0/5)或MPMs(NHB为0/11,西班牙裔为0/4)的个体接受RRM。
我们的研究结果表明,种族和族裔可能与接受RRM的决定有关。